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the ETBgene, 2) A highly conserved region in its 5’UTR harbors an element
responsible for high level expression of a reporter gene in cells expressing
ETB.These elements may help us understand ETB regulation during neural
crest development and in conditions associated with endothelial dysfunction
auch as heart failure, pulmonaty hypetiension and atherosclerosis.
m1074122 Aldosterone synthese gene polymorphism
medicts left ventricular size end function in
pereons free of heert dieeese
A. Hautanen, M. Kupari, P.Koskinen, J. Virolainen, H. Nikkil~, L. Lankinen,
P.C.White. Department of Medicine, University of Helsinki, Finland,
Department of Pediatrics, Univeraityof TexasSouthwestern Medical Center,
Dallas, TX, USA
Aldosterone has many effects on heart and circulation. Genetic variation in
aldoaterone synthesis could therefore have esrdiac implications. Aldosterone
synthase (CYPI1 B2) catalyzes the last steps of aldosterone formation. We
atudiad whether CYPIIB2 gene .polymorphism predicts left ventricular (LV)
size, mass or function in humans.
84 persons (40 men) free of heart disease born in 1954 were studied by
M-mode and Doppler eehocardi09raPhYand genotyped by polymerasechain
reaetion for –344 cytosinehhymidine (C/T) polymorphism in the promoter of
the CYPll B2gene. The LVmeasurements (mean *SD) bythe CrTgenotypS
group were as follows:
Measurement -3441T n. 22 –344CTn=42 –244CCn= 20 P(anova)
EDD,mm 47* 3 50*4 51l 4 0.002
ESD,mm 31+3 34*4 35+6 0.013
Mass,g 149*39 169+46 182+58 0.0B2
EIA 1.7* 0.3 1.5+ 0.3 1.6+ 0.3 0.024
AFF,‘h 23+ 6 27* 6 26+6 0,004
EDD = end-diastolic diameter; ESD = end-systolic diameter; E/A= trans-
mittal earfy/atrial velocity ratio; AFF = atrial filling fraction. The influence of
CYPIIB2 genotype on LV measurements was independent of sex, body
size, blood pressure and salt intake.
We conclude that DNA polymorphism in the CYP11B2 gene predicts LV
structure and function in persons free of heart disease.
m1074123 Effect of Estrogen on Protein and DNASynthesie and Estrogen Receptor Statua in
Cerdiac Fibroblasts
A.V. Sigel, G.A.J. Riegger, H. Schunkert. Depaflnrent ofkrtefnal &fedicin //,
Universifyof Regerwtwrg, Germany
Estrogen exerta a clinically relevant anti-atherogenic effect in women. In ad-
dition, eetrogen may bind to receptors on vascular smooth muscle cells and
modulate the growth of these cells. Little, however, is known about its direct
effects on cardiac fibroblasts, which are responsible for exfraeellular matrix
production in the heart. We, therefore, investigated the role of estrogen on
male adult rabbit cardiac fibroblasts, which were grown until subeonfluent
in DMEM supplemented with IOYOFBS. Western immuno slot blot analysis
demonstrated that eardiacfibroblast.sexpress estrogen reeaptorprotein. The
density of the eetrogen receptor significantly increased with the degree of
conflueney from 24 through 120 houra in culture (685%, p = 0.005). Next, we
investigated theeffectcIf estro9en on DNAsynthesis measuring 3H-thymidine
incorporation. Estrogen dose-dependently decreased DNA synthesis of car-
diac fibroblasts. The maximum decrease was observed with 10 nM estrogen
(78%, p =0.0005). In addition, estrogen treatment decreased protein synthe-
sis, as measured by 3H-phenylalanine incorporation by 64% (p < O.O@I). In
contrast, transforming growth factor bata 1 (TGF-fJI) protein concentrations
increased by 178% (p < 0.05). Furthermore, treatment with 10 nM, 500 nM,
and 10 r.tMexogenous estrogen further increased estrogen receptor protein
immunoreaetivity by 13°A (p < 0.0005), 17% (p < 0.005), and 16% (p <
0.005), respectively. We, therefore, conclude that estrogens modulate pro-
tein and DNAsyiitheais in cardiac fibroblasts. The anti-proliferative effa@ of
estrogen may involve the induction of TGF-BI and/or a positive feedback on
the expression of its receptor.
m1074124 Interaction Between Estradiol and MechanicalStrain in Human Vasculer Smooth Muecle Cells
unknown. A direct inhibitoy effect on vascular smooth muscle growth has
been proposed, but conflicting data exist, ahowing stimulation of mitogenesis
under some circumstances. We examined the effect of different concentra-
tions of 17@-estradiolon mitogenesis induced by cyclic mechanical strain in
human vascular smooth muscle cells in culture. Cells were grown to con-
fluence on fibronectin-coated plates with silicone-elastomer bottoms. They
were then expoeed to cyclic mechanical strain (60 cyclea/min, 46 h), in the
presence and absence of 17@-estradiol(1 nM or 1 vM). 3H-Thymidine was
measured during the last six hours. Cyclic mechanical strain induced 1.5 to
2 fold increasee in DNA syntheeis. While estradiol, 1 nM caused an inhibi-
tion of strain-induced mitogenesis, estradiol 1 KM caused an enhancement.
Thymidine incorporation data (cpmJwell)are shown below.
Control 3e34& 386
Strain 6753 & 386
Strain+ Estradiol1 nM 3397*465
Strain+ Estradiol1 WM S875 & 515
The extent of inhibition of strain-induced mitogenesis by physiological
concentrations of estradiol (1 nM) was attenuated by the estrogen receptor
antagonist ICI 182,780 (1 nM). We conclude that estrogen, in physiological
concentrations, inhibits strain-induced mitogenesis via an estrogen-receptor
mediated process, and in supraphysiological concentrations, stimulates mi-
togenesis, probably via non-specific steroid effects. Our observations may
have implications for the cardiovascular benefits of low dose eetrogens and
the risks associated with high dose estrogens seen in epidemiological stud-
ies.
m1074125 Proteinaae Activated Receptor-2(PAR-2)-Mediated Mitogenic Responeea Are
Induced By Human Mast Cell Tryptases
H. Mirza, V. Schmidt, J. Jesty, W.F.Bahou. State Univeraityof New Yorkat
Stony Brook, USA
PAR-2 is the second proteolytically activated receptor that mediates cell
activation events by receptor cleavage. PAR-2 is expreseed on vaacular
endothelial cells and is functionally coupled to the thrombin receptor (TR)
in vitro. To further study previously identified mitogenic effects of PAR-2,
we utilized the IL-3-dependent murine Iymphoid cell line BaF3 to gener-
ate a stable cell line expressing PAR-2 (BaF3/PAR-2). Both wild-type BaF3
and BaF3/PAR-2cells demonstrated proliferative responsea when incubated
with! 10%WEHI media (as the source of IL-3), as evaluated by MTT asaay..ln
contrast, only BaF3/PAR-2 cells exhibitad mitogenic responses when grown
in IL-3-deficient media supplemented with PAR-2 activating peptide (SLl-
GRL, PARW-U). No responses were evident in BaF3/PAR-2 cells using the
inactive peptide LSIGRL. Xenopus oocytes microinjectad with PAR-2 cRNA
demonstrated a dose-dependent responsiveness to the thrombin receptor
activating peptide (TR@-47SFLLRN), and incubation of BaF3/PAR-2 cella
with 100 KM TR42–-47for 46 houre reproduced the proliferative response,
although at -75Y0 of that identified using equimolar PARW––W. Because
tryptase shares -70% homology with trypsin (previously shown to activate
PAR-2), we evaluated whether expressed forms of a- and p-tryptaee could
induce proliferative responses in BaF3/PAR-2 cells. Transient tranefaetion of
COS-I cells with human mast cell a- and @-ttyptasecDNA’s demonstrated
tryptase expression in supematants and cells extracts for both forms, aa
evaluated by quantitative radioimmunoassay. Comparable proliferative r-
sponses were evident using conditioned media from either a- or &tryptaae
expressad forms, whereas such responses were limited to wttyptase cell ex-
tracts only. These results identify mast cell tryptases as physiological serine
proteaee agonists for PAR-2 with implications for elucidating the molec-
ular mechanisms regulating cell activation events mediated by proteases
generatad at the cell-surface during inflammatory, fibrinolytic or thrombosia-
regulated pathways.
in Culture
K. Sudhir, S. Ling, T.M. Chou, H.E. Ives, K. Chatterjae. Universifyof
California, San Francisco, CA, USA
The cellular basis of the eardioprotective effects of estrogen are largely
